Angus, Steven P. http://orcid.org/0000-0002-7655-657X
Stuhlmiller, Timothy J.
Mehta, Gaurav
Bevill, Samantha M.
Goulet, Daniel R.
Olivares-Quintero, J. Felix
East, Michael P.
Tanioka, Maki
Zawistowski, Jon S.
Singh, Darshan
Sciaky, Noah
Chen, Xin
He, Xiaping
Rashid, Naim U.
Chollet-Hinton, Lynn http://orcid.org/0000-0001-9748-861X
Fan, Cheng
Soloway, Matthew G.
Spears, Patricia A.
Jefferys, Stuart http://orcid.org/0000-0001-6259-085X
Parker, Joel S. http://orcid.org/0000-0003-2080-6901
Gallagher, Kristalyn K. http://orcid.org/0000-0002-6036-6763
Forero-Torres, Andres
Krop, Ian E.
Thompson, Alastair M.
Murthy, Rashmi
Gatza, Michael L. http://orcid.org/0000-0001-6796-7791
Perou, Charles M. http://orcid.org/0000-0001-9827-2247
Earp, H. Shelton http://orcid.org/0000-0003-1229-4619
Carey, Lisa A. http://orcid.org/0000-0003-2388-4649
Johnson, Gary L. http://orcid.org/0000-0003-2867-0551
Article History
Received: 11 April 2020
Accepted: 8 April 2021
First Online: 12 May 2021
Competing interests
: H.S.E. is a co-founder of Meryx. C.M.P. is an equity stockholder and Board of Directors Member of BioClassifier LLC and University Genomics and is an inventor on a patent application on the PAM50 molecular assay. J.S.P. holds patents on the PAM50 classifier that are licensed to Nanostring. A.F.-T. declared research support paid to his institutions from Genentech/Roche, Seattle Genetics, Pfizer, Novartis, 47, Incyte, GSK, Affimed, Lilly. A.F.-T. is on the speaker bureau with Seattle Genetics. A.M.T. declares an honorarium and travel received from Pfizer. I.E.K. declares research support paid to his institutions from Genentech/Roche, and Pfizer and honoraria from Bristol Meyers Squibb, Daiichi/Sankyo, Macrogenics, Context Therapeutics, Taiho Oncology, Genentech/Roche, and Seattle Genetics, and serves on Data Safety Monitoring Committees for Novartis and Merck. No potential conflicts of interest were disclosed by the other authors.